{"transactions":[{"id":2181805,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":124480,"kind":"person","name":"TOMBESI PAOLO","position":1,"cik":"0001707648","reported_name":"TOMBESI PAOLO","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-08-17T16:31:35.000Z","date":"2022-08-17","kind":"disposition_to_issuer","acquired":false,"shares":58600,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"At the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option was accelerated and became fully vested and exercisable and was cancelled and automatically converted into the right to receive cash, without interest, in an amount equal to the product of (i) the total number of Shares subject to such option multiplied by (ii) the excess of (x) $76.00 per Share over (y) the exercise price payable per Share under such option, net of any withholding taxes required to be deducted and withheld by applicable law."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"At the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option was accelerated and became fully vested and exercisable and was cancelled and automatically converted into the right to receive cash, without interest, in an amount equal to the product of (i) the total number of Shares subject to such option multiplied by (ii) the excess of (x) $76.00 per Share over (y) the exercise price payable per Share under such option, net of any withholding taxes required to be deducted and withheld by applicable law."}],"balance_after":0,"derivative":{"exercise_price":37.68,"expiration_date":"2032-02-08","underlying":"Common Stock","underlying_shares":58600},"source":{"system":"sec-edgar","filing":"0001209191-22-046272","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1707648/000120919122046272/doc4.xml","form_type":"4"}},{"id":2181804,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":124480,"kind":"person","name":"TOMBESI PAOLO","position":1,"cik":"0001707648","reported_name":"TOMBESI PAOLO","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-08-17T16:31:35.000Z","date":"2022-08-17","kind":"disposition_to_issuer","acquired":false,"shares":61200,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"At the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option was accelerated and became fully vested and exercisable and was cancelled and automatically converted into the right to receive cash, without interest, in an amount equal to the product of (i) the total number of Shares subject to such option multiplied by (ii) the excess of (x) $76.00 per Share over (y) the exercise price payable per Share under such option, net of any withholding taxes required to be deducted and withheld by applicable law."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"At the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option was accelerated and became fully vested and exercisable and was cancelled and automatically converted into the right to receive cash, without interest, in an amount equal to the product of (i) the total number of Shares subject to such option multiplied by (ii) the excess of (x) $76.00 per Share over (y) the exercise price payable per Share under such option, net of any withholding taxes required to be deducted and withheld by applicable law."}],"balance_after":0,"derivative":{"exercise_price":62.63,"expiration_date":"2031-07-25","underlying":"Common Stock","underlying_shares":61200},"source":{"system":"sec-edgar","filing":"0001209191-22-046272","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707648/000120919122046272/doc4.xml","form_type":"4"}},{"id":2181803,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":124480,"kind":"person","name":"TOMBESI PAOLO","position":1,"cik":"0001707648","reported_name":"TOMBESI PAOLO","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-08-17T16:31:35.000Z","date":"2022-08-17","kind":"disposition_to_issuer","acquired":false,"shares":29778,"price":76,"value":2263128.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of June 2, 2022, by and among Turning Point Therapeutics, Inc. (the \"Issuer\"), Bristol-Myers Squibb Company (\"BMS\") and Rhumba Merger Sub Inc., a wholly owned subsidiary of BMS (\"Purchaser\"), on August 17, 2022, Purchaser completed a tender offer for shares of common stock of the Issuer (each, a \"Share\") and thereafter merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of BMS (the \"Merger\"). At the effective time of the Merger, each issued and outstanding Share was cancelled in exchange for $76.00 per Share in cash, without interest, subject to any applicable withholding of taxes (the \"Cash Amount\"). Pursuant to the terms of the Merger Agreement, the Shares were tendered and disposed of at the Offer Acceptance Time (as defined in the Merger Agreement) in exchange for the right to receive the Cash Amount."},{"field":"shares","element":"transactionShares","label":"F2","text":"At the effective time of the Merger, pursuant to the Merger Agreement, each outstanding restricted stock unit award (\"RSU\") whether vested or unvested was cancelled and automatically converted into the right to receive cash, without interest, in an amount equal to $76.00 per Share issuable in settlement of such RSU immediately before the effective time of the Merger, net of any withholding taxes required to be deducted and withheld by applicable law."},{"field":"shares","element":"transactionShares","label":"F3","text":"Includes 1,078 shares acquired on June 10, 2022 pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-22-046272","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707648/000120919122046272/doc4.xml","form_type":"4"}},{"id":2200304,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":124480,"kind":"person","name":"TOMBESI PAOLO","position":1,"cik":"0001707648","reported_name":"TOMBESI PAOLO","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-07-29T16:18:14.000Z","date":"2022-07-27","kind":"sale","acquired":false,"shares":1183,"price":74.94,"value":88654.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares of common stock to cover tax withholding obligations associated with the vesting of a restricted stock unit award granted to Reporting Person on July 26, 2021."}],"balance_after":28700,"source":{"system":"sec-edgar","filing":"0001209191-22-043510","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707648/000120919122043510/doc4.xml","form_type":"4"}},{"id":2401804,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":124480,"kind":"person","name":"TOMBESI PAOLO","position":1,"cik":"0001707648","reported_name":"TOMBESI PAOLO","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-11T18:11:13.000Z","date":"2022-02-09","kind":"grant","acquired":true,"shares":58600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48th of the shares vest monthly following February 9, 2022."}],"balance_after":58600,"derivative":{"exercise_price":37.68,"expiration_date":"2032-02-08","underlying":"Common Stock","underlying_shares":58600},"source":{"system":"sec-edgar","filing":"0001209191-22-008985","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707648/000120919122008985/doc4.xml","form_type":"4"}},{"id":2401803,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":124480,"kind":"person","name":"TOMBESI PAOLO","position":1,"cik":"0001707648","reported_name":"TOMBESI PAOLO","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-02-11T18:11:13.000Z","date":"2022-02-09","kind":"grant","acquired":true,"shares":16283,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2019 Equity Plan."}],"balance_after":29883,"source":{"system":"sec-edgar","filing":"0001209191-22-008985","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707648/000120919122008985/doc4.xml","form_type":"4"}},{"id":2623840,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":124480,"kind":"person","name":"TOMBESI PAOLO","position":1,"cik":"0001707648","reported_name":"TOMBESI PAOLO","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-07-27T18:22:14.000Z","date":"2021-07-26","kind":"grant","acquired":true,"shares":61200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares vest on July 26, 2022 and 1/48th of the shares vest monthly thereafter over the next three years."}],"balance_after":61200,"derivative":{"exercise_price":62.63,"expiration_date":"2031-07-25","underlying":"Common Stock","underlying_shares":61200},"source":{"system":"sec-edgar","filing":"0001209191-21-048337","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707648/000120919121048337/doc4.xml","form_type":"4"}},{"id":2623839,"issuer":{"id":124461,"kind":"organization","name":"Turning Point Therapeutics, Inc.","symbol":"TPTX"},"owners":[{"id":124480,"kind":"person","name":"TOMBESI PAOLO","position":1,"cik":"0001707648","reported_name":"TOMBESI PAOLO","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-07-27T18:22:14.000Z","date":"2021-07-26","kind":"grant","acquired":true,"shares":13600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2019 Equity Incentive Plan."}],"balance_after":13600,"source":{"system":"sec-edgar","filing":"0001209191-21-048337","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707648/000120919121048337/doc4.xml","form_type":"4"}},{"id":2876700,"issuer":{"id":12703,"kind":"organization","name":"Epizyme, Inc.","symbol":"EPZM"},"owners":[{"id":124480,"kind":"person","name":"TOMBESI PAOLO","position":1,"cik":"0001707648","reported_name":"TOMBESI PAOLO","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2021-02-05T16:40:56.000Z","date":"2021-02-04","kind":"sale","acquired":false,"shares":1021,"price":11.21,"value":11445.41,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically sold by the reporting person to satisfy tax withholding obligations in connection with the vesting of the restricted stock units granted under the issuer's 2013 Stock Incentive Plan on February 3, 2020. The automatic sale of the reporting person's shares is provided for in a restricted stock unit agreement constituting a \"binding contract\" consistent with the affirmative defense to liability under Rule 10b5-1 and the sale does not represent a discretionary trade by the reporting person."}],"balance_after":53465,"source":{"system":"sec-edgar","filing":"0000899243-21-005042","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707648/000089924321005042/doc4.xml","form_type":"4"}},{"id":2885855,"issuer":{"id":12703,"kind":"organization","name":"Epizyme, Inc.","symbol":"EPZM"},"owners":[{"id":124480,"kind":"person","name":"TOMBESI PAOLO","position":1,"cik":"0001707648","reported_name":"TOMBESI PAOLO","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-02T21:07:56.000Z","date":"2021-02-01","kind":"grant","acquired":true,"shares":124239,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on February 1, 2021 pursuant to the Company's 2013 Stock Incentive Plan with respect to 124,239 shares of Common Stock, with 25% vesting on February 1, 2022 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":124239,"derivative":{"exercise_price":11.02,"expiration_date":"2031-01-31","underlying":"Common Stock","underlying_shares":124239},"source":{"system":"sec-edgar","filing":"0000899243-21-004516","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707648/000089924321004516/doc4.xml","form_type":"4"}},{"id":2885854,"issuer":{"id":12703,"kind":"organization","name":"Epizyme, Inc.","symbol":"EPZM"},"owners":[{"id":124480,"kind":"person","name":"TOMBESI PAOLO","position":1,"cik":"0001707648","reported_name":"TOMBESI PAOLO","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-02-02T21:07:56.000Z","date":"2021-02-01","kind":"grant","acquired":true,"shares":26041,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Plan. Each RSU represents the right to receive one share of Common Stock upon vesting. These RSUs are scheduled to vest in four equal annual installments over four years from the grant date, with the first installment vesting on February 1, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reporting person acquired 996 shares of Common Stock under the Issuer's 2013 Employee Stock Purchase Plan (the \"2013 ESPP\") on February 29, 2020 that were not previously reported on Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The reporting person acquired 543 shares of Common Stock under the 2013 ESPP on August 31, 2020."}],"balance_after":54486,"source":{"system":"sec-edgar","filing":"0000899243-21-004516","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707648/000089924321004516/doc4.xml","form_type":"4"}},{"id":3050008,"issuer":{"id":12703,"kind":"organization","name":"Epizyme, Inc.","symbol":"EPZM"},"owners":[{"id":124480,"kind":"person","name":"TOMBESI PAOLO","position":1,"cik":"0001707648","reported_name":"TOMBESI PAOLO","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2020-08-21T16:15:21.000Z","date":"2020-08-19","kind":"exercise","acquired":true,"shares":7055,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On August 19, 2019, the reporting person was granted 28,217 restricted stock units, vesting in four equal annual installments beginning August 19, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On August 19, 2019, the reporting person was granted 28,217 restricted stock units, vesting in four equal annual installments beginning August 19, 2020."}],"balance_after":21162,"derivative":{"underlying":"Common Stock","underlying_shares":7055},"source":{"system":"sec-edgar","filing":"0000899243-20-023197","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1707648/000089924320023197/doc4.xml","form_type":"4"}},{"id":3050007,"issuer":{"id":12703,"kind":"organization","name":"Epizyme, Inc.","symbol":"EPZM"},"owners":[{"id":124480,"kind":"person","name":"TOMBESI PAOLO","position":1,"cik":"0001707648","reported_name":"TOMBESI PAOLO","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2020-08-21T16:15:21.000Z","date":"2020-08-20","kind":"tax_withholding","acquired":false,"shares":2091,"price":12.55,"value":26242.05,"ownership":{"direct":true},"balance_after":26906,"source":{"system":"sec-edgar","filing":"0000899243-20-023197","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707648/000089924320023197/doc4.xml","form_type":"4"}},{"id":3050006,"issuer":{"id":12703,"kind":"organization","name":"Epizyme, Inc.","symbol":"EPZM"},"owners":[{"id":124480,"kind":"person","name":"TOMBESI PAOLO","position":1,"cik":"0001707648","reported_name":"TOMBESI PAOLO","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2020-08-21T16:15:21.000Z","date":"2020-08-19","kind":"exercise","acquired":true,"shares":7055,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units convert into common stock on a one-for-one basis."}],"balance_after":28997,"source":{"system":"sec-edgar","filing":"0000899243-20-023197","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707648/000089924320023197/doc4.xml","form_type":"4"}},{"id":3096692,"issuer":{"id":12703,"kind":"organization","name":"Epizyme, Inc.","symbol":"EPZM"},"owners":[{"id":124480,"kind":"person","name":"TOMBESI PAOLO","position":1,"cik":"0001707648","reported_name":"TOMBESI PAOLO","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2020-06-30T08:57:04.000Z","date":"2020-06-26","kind":"sale","acquired":false,"shares":1805,"price":16.15,"value":29150.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares automatically sold by the reporting person to satisfy tax withholding obligations in connection with the vesting of the restricted stock units described in footnote 1.  The automatic sale of the reporting person's shares is provided for in a restricted stock unit agreement constituting a \"binding contract\" consistent with the affirmative defense to liability under Rule 10b5-1 and the sale does not represent a discretionary trade by the reporting person."}],"balance_after":21942,"source":{"system":"sec-edgar","filing":"0000899243-20-017902","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707648/000089924320017902/doc4.xml","form_type":"4"}},{"id":3096691,"issuer":{"id":12703,"kind":"organization","name":"Epizyme, Inc.","symbol":"EPZM"},"owners":[{"id":124480,"kind":"person","name":"TOMBESI PAOLO","position":1,"cik":"0001707648","reported_name":"TOMBESI PAOLO","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2020-06-30T08:57:04.000Z","date":"2020-06-25","kind":"grant","acquired":true,"shares":6000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents common stock issued upon vesting of restricted stock units granted under the issuer's 2013 Stock Incentive Plan that vested upon the issuer's achievement of a specified performance target. The transaction date represents the date on which the issuer's Compensation Committee determined that the performance target was achieved."}],"balance_after":23747,"source":{"system":"sec-edgar","filing":"0000899243-20-017902","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707648/000089924320017902/doc4.xml","form_type":"4"}},{"id":3096690,"issuer":{"id":12703,"kind":"organization","name":"Epizyme, Inc.","symbol":"EPZM"},"owners":[{"id":124480,"kind":"person","name":"TOMBESI PAOLO","position":1,"cik":"0001707648","reported_name":"TOMBESI PAOLO","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2020-06-30T06:06:52.000Z","date":"2020-03-24","kind":"grant","acquired":true,"shares":4000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Form 4 originally filed on March 26, 2020 inadvertently reported an incorrect amount of shares of common stock issued to the reporting person upon vesting of restricted stock units granted under the issuer's 2013 Stock Incentive Plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Form 4 originally filed on March 26, 2020 inadvertently reported an incorrect amount of shares of common stock issued to the reporting person upon vesting of restricted stock units granted under the issuer's 2013 Stock Incentive Plan."}],"balance_after":17747,"source":{"system":"sec-edgar","filing":"0000899243-20-017854","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707648/000089924320017854/doc4a.xml","form_type":"4/A","original_submission_date":"2020-03-26"}},{"id":3194446,"issuer":{"id":12703,"kind":"organization","name":"Epizyme, Inc.","symbol":"EPZM"},"owners":[{"id":124480,"kind":"person","name":"TOMBESI PAOLO","position":1,"cik":"0001707648","reported_name":"TOMBESI PAOLO","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2020-03-26T21:01:41.000Z","date":"2020-03-25","kind":"sale","acquired":false,"shares":1243,"price":15.28,"value":18993.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares automatically sold by the reporting person to satisfy tax withholding obligations in connection with the vesting of the restricted stock units described in footnote 1.  The automatic sale of the reporting person's shares is provided for in a restricted stock unit agreement constituting a \"binding contract\" consistent with the affirmative defense to liability under Rule 10b5-1 and the sale does not represent a discretionary trade by the reporting person."}],"balance_after":15437,"source":{"system":"sec-edgar","filing":"0000899243-20-009607","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707648/000089924320009607/doc4.xml","form_type":"4"}},{"id":3194445,"issuer":{"id":12703,"kind":"organization","name":"Epizyme, Inc.","symbol":"EPZM"},"owners":[{"id":124480,"kind":"person","name":"TOMBESI PAOLO","position":1,"cik":"0001707648","reported_name":"TOMBESI PAOLO","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2020-03-26T21:01:41.000Z","date":"2020-03-24","kind":"grant","acquired":true,"shares":1690,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents common stock issued upon vesting of restricted stock units granted under the issuer's 2013 Stock Incentive Plan that vested upon the issuer's achievement of a specified performance target. The transaction date represents the date on which the issuer's Compensation Committee determined that the performance target was achieved."}],"balance_after":16680,"source":{"system":"sec-edgar","filing":"0000899243-20-009607","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707648/000089924320009607/doc4.xml","form_type":"4"}},{"id":3288901,"issuer":{"id":12703,"kind":"organization","name":"Epizyme, Inc.","symbol":"EPZM"},"owners":[{"id":124480,"kind":"person","name":"TOMBESI PAOLO","position":1,"cik":"0001707648","reported_name":"TOMBESI PAOLO","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-05T18:00:18.000Z","date":"2020-02-03","kind":"grant","acquired":true,"shares":56213,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on February 3, 2020 pursuant to the Company's 2013 Stock Incentive Plan with respect to 56,213 shares of Common Stock, with 25% vesting on February 3, 2021 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":56213,"derivative":{"exercise_price":21.39,"expiration_date":"2030-02-02","underlying":"Common Stock","underlying_shares":56213},"source":{"system":"sec-edgar","filing":"0000899243-20-003366","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707648/000089924320003366/doc4.xml","form_type":"4"}},{"id":3288900,"issuer":{"id":12703,"kind":"organization","name":"Epizyme, Inc.","symbol":"EPZM"},"owners":[{"id":124480,"kind":"person","name":"TOMBESI PAOLO","position":1,"cik":"0001707648","reported_name":"TOMBESI PAOLO","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-02-05T18:00:18.000Z","date":"2020-02-03","kind":"grant","acquired":true,"shares":11688,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares of Common Stock issuable under 11,688 restricted stock units (\"RSUs\") granted pursuant to the Company's 2013 Stock Incentive Plan. Each RSU represents the right to receive one share of Common Stock upon vesting. These RSUs are scheduled to vest in four equal annual installments over four years from the grant date, with the first installment vesting on February 3, 2021."}],"balance_after":14990,"source":{"system":"sec-edgar","filing":"0000899243-20-003366","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707648/000089924320003366/doc4.xml","form_type":"4"}},{"id":3301402,"issuer":{"id":12703,"kind":"organization","name":"Epizyme, Inc.","symbol":"EPZM"},"owners":[{"id":124480,"kind":"person","name":"TOMBESI PAOLO","position":1,"cik":"0001707648","reported_name":"TOMBESI PAOLO","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2020-01-27T21:15:35.000Z","date":"2020-01-23","kind":"tax_withholding","acquired":false,"shares":1698,"price":26.72,"value":45370.56,"ownership":{"direct":true},"balance_after":3302,"source":{"system":"sec-edgar","filing":"0000899243-20-002109","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707648/000089924320002109/doc4.xml","form_type":"4"}},{"id":3301401,"issuer":{"id":12703,"kind":"organization","name":"Epizyme, Inc.","symbol":"EPZM"},"owners":[{"id":124480,"kind":"person","name":"TOMBESI PAOLO","position":1,"cik":"0001707648","reported_name":"TOMBESI PAOLO","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.0001","published_at":"2020-01-27T21:15:35.000Z","date":"2020-01-23","kind":"grant","acquired":true,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents common stock issued upon vesting of restricted stock units granted under the issuer's 2013 Stock Incentive Plan that vested upon the issuer's achievement of a specified performance target. The transaction date represents the date on which the issuer's Compensation Committee determined that the performance target was achieved."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0000899243-20-002109","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707648/000089924320002109/doc4.xml","form_type":"4"}},{"id":3432176,"issuer":{"id":12703,"kind":"organization","name":"Epizyme, Inc.","symbol":"EPZM"},"owners":[{"id":124480,"kind":"person","name":"TOMBESI PAOLO","position":1,"cik":"0001707648","reported_name":"TOMBESI PAOLO","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2019-08-21T06:06:31.000Z","date":"2019-08-19","kind":"grant","acquired":true,"shares":28217,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the contingent right to receive one share of Epizyme, Inc. common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This award, granted on August 19, 2019, pursuant to the Company's 2013 Stock Incentive Plan, vests in four equal annual installments beginning August 19, 2020. Vested shares will be delivered to the reporting person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This award, granted on August 19, 2019, pursuant to the Company's 2013 Stock Incentive Plan, vests in four equal annual installments beginning August 19, 2020. Vested shares will be delivered to the reporting person."}],"balance_after":28217,"derivative":{"underlying":"Common Stock","underlying_shares":28217},"source":{"system":"sec-edgar","filing":"0000899243-19-022189","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707648/000089924319022189/doc4.xml","form_type":"4"}},{"id":3432175,"issuer":{"id":12703,"kind":"organization","name":"Epizyme, Inc.","symbol":"EPZM"},"owners":[{"id":124480,"kind":"person","name":"TOMBESI PAOLO","position":1,"cik":"0001707648","reported_name":"TOMBESI PAOLO","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-08-21T06:06:31.000Z","date":"2019-08-19","kind":"grant","acquired":true,"shares":132225,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on August 19, 2019 pursuant to the Company's 2013 Stock Incentive Plan with respect to 132,225 shares of Epizyme, Inc. common stock, with 25% vesting on August 19, 2020 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":132225,"derivative":{"exercise_price":13.86,"expiration_date":"2029-08-18","underlying":"Common Stock","underlying_shares":132225},"source":{"system":"sec-edgar","filing":"0000899243-19-022189","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707648/000089924319022189/doc4.xml","form_type":"4"}},{"id":3702190,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":124480,"kind":"person","name":"TOMBESI PAOLO","position":1,"cik":"0001707648","reported_name":"TOMBESI PAOLO","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2019-01-07T21:08:29.000Z","date":"2019-01-03","kind":"grant","acquired":true,"shares":120280,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options granted under the Company's 2017 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty-five percent (25%) on the first anniversary of the grant date and an additional twelve and one-half percent (12.5%) vest on the six month anniversary of the first anniversary date and each six month anniversary date thereafter through the fourth anniversary of the date of grant."}],"balance_after":120280,"derivative":{"exercise_price":13.91,"expiration_date":"2029-01-03","underlying":"Common Stock","underlying_shares":120280},"source":{"system":"sec-edgar","filing":"0001127430-19-000018","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000112743019000018/edgar.xml","form_type":"4"}},{"id":4104423,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":124480,"kind":"person","name":"TOMBESI PAOLO","position":1,"cik":"0001707648","reported_name":"TOMBESI PAOLO","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2018-01-08T21:11:46.000Z","date":"2018-01-04","kind":"grant","acquired":true,"shares":55400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Stock options granted under the Company's 2017 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty-five percent (25%) on the first anniversary of the grant date and an additional twelve and one-half percent (12.5%) vest on the six month anniversary of the first anniversary date and each six month anniversary date thereafter through the fourth anniversary of the date of grant."}],"balance_after":55400,"derivative":{"exercise_price":30.46,"expiration_date":"2028-01-04","underlying":"Common Stock","underlying_shares":55400},"source":{"system":"sec-edgar","filing":"0001127430-18-000021","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000112743018000021/edgar.xml","form_type":"4"}},{"id":4104422,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":124480,"kind":"person","name":"TOMBESI PAOLO","position":1,"cik":"0001707648","reported_name":"TOMBESI PAOLO","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-01-08T21:11:46.000Z","date":"2018-01-04","kind":"grant","acquired":true,"shares":10669,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units granted pursuant to the Company's 2017 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit was received as a grant on January 4, 2018, for no consideration, and represents a contingent right to receive one share of Common Stock."}],"balance_after":10669,"source":{"system":"sec-edgar","filing":"0001127430-18-000021","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000112743018000021/edgar.xml","form_type":"4"}},{"id":4293353,"issuer":{"id":3174,"kind":"organization","name":"INSMED Inc","symbol":"INSM"},"owners":[{"id":124480,"kind":"person","name":"TOMBESI PAOLO","position":1,"cik":"0001707648","reported_name":"TOMBESI PAOLO","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2017-06-05T20:09:00.000Z","date":"2017-06-01","kind":"grant","acquired":true,"shares":127160,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection with the appointment of Mr. Tombesi as the Company's Chief Financial Officer, the Company granted Mr. Tombesi an option to purchase a total of 127,160 shares of the Company's common stock.  The option becomes exercisable based on the following vesting schedule: twenty-five percent (25%) vest on the first anniversary of the date of grant and twelve and one-half percent (12.5%) vest on each six month anniversary date through the fourth anniversary of the date of grant, subject to Mr. Tombesi's continued employment with the Company on each vesting date."}],"balance_after":127160,"derivative":{"exercise_price":15.6,"expiration_date":"2027-06-01","underlying":"Common Stock","underlying_shares":127160},"source":{"system":"sec-edgar","filing":"0001127430-17-000065","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1104506/000112743017000065/edgar.xml","form_type":"4"}}]}